Alkermes (ALKS) EBT Margin (2010 - 2026)
Alkermes (ALKS) recorded EBT Margin of 3.07% in Q3 2026, down 22.49 percentage points from 25.56% a year earlier but up 3.45 percentage points from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) EBT Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Alkermes' EBT Margin came in at 0.65% as of Sep 30, 2026, down 25.71 percentage points year-over-year; for FY2025, it was 19.75%, down 8.74 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +29.04 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 28.49% in FY2024 (+3.15 pp), 25.34% in FY2023 (+28.14 pp), -2.80% in FY2022 (-10.27 pp) and 7.47% in FY2021 (+16.77 pp).
- Quarterly EBT Margin has ranged from -26.70% in Q3 2022 to 45.65% in Q2 2023 over the past five years.
- On a year-over-year basis, EBT Margin has declined for seven consecutive quarters, with an average year-over-year change of -10.58 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 57.69 percentage points in Q2 2023, against a drop of 27.21 percentage points in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -0.38% (Q2 2026), -15.76% (Q1 2026) and 15.70% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 20.41% |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | 3.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.07% |
| Jun 30, 2026 | -0.38% |
| Mar 31, 2026 | -15.76% |
| Dec 31, 2025 | 15.70% |
| Sep 30, 2025 | 25.56% |
| Jun 30, 2025 | 26.84% |
| Mar 31, 2025 | 8.32% |
| Dec 31, 2024 | 39.51% |
| Sep 30, 2024 | 29.15% |
| Jun 30, 2024 | 29.24% |
| Mar 31, 2024 | 13.39% |
| Dec 31, 2023 | 15.45% |
| Sep 30, 2023 | 24.34% |
| Jun 30, 2023 | 45.65% |
| Mar 31, 2023 | -3.94% |
| Dec 31, 2022 | 37.58% |
| Sep 30, 2022 | -26.70% |
| Jun 30, 2022 | -12.04% |
| Mar 31, 2022 | -16.15% |
| Dec 31, 2021 | 39.22% |
API Access
Alkermes EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();